Investigation of Maintaining Visual Performance Achieved With Cyclosporine Therapy

Completed · Phase 4

Conditions studied: Dry Eye Syndromes

In brief

This study will evaluate the safety and efficacy of cyclosporine 0.05% ophthalmic emulsion (Restasis®) in patients with dry eye disease.

Key facts

Study ID

NCT02121847

Run by

Allergan

People needed

40

Starts

2014-04-03

Expected to finish

2014-09-23

Last updated by the study team

2019-04-18

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• History of dry eye in both eyes
• Willing to use eye drops for dry eye symptoms

You may not qualify if…

• Anticipate wearing contact lenses during the study
• Laser-assisted in situ keratomileusis (LASIK) surgery within the past 12 months
• Any ocular and/or lid surgeries within the past 6 months
• Cataract surgery in either eye
• Current or anticipated use of temporary punctal plugs during the study

Where it is running

• Study site — Andover, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.